January 23, 2025
•
Press Releases
Latest
Beckman Coulter Diagnostics Joins the Transformative Bio-Hermes-002 Study as New Partner
Washington D.C., Jan. 23, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes-002 study. This first-time collaboration will enhance this unique, observational platform study that compares blood-based and digital biomarkers across a broad range of clinical cognitive conditions, MRI and PET images […]
Alzheimer's disease
Alzheimers
Beckman Coulter Diagnostics
Bio-Hermes-002
biomarkers
clinical research
GAP
Innovation
Research
